Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 6 studies | 26% ± 9% | |
GABAergic neuron | 3 studies | 19% ± 1% | |
glutamatergic neuron | 3 studies | 29% ± 4% | |
dendritic cell | 3 studies | 27% ± 5% | |
transit amplifying cell | 3 studies | 24% ± 8% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
liver | 3 studies | 23% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 1668.50 | 459 / 459 | 100% | 14.24 | 1118 / 1118 |
esophagus | 100% | 1607.04 | 1445 / 1445 | 100% | 18.92 | 183 / 183 |
intestine | 100% | 1440.91 | 966 / 966 | 100% | 14.15 | 527 / 527 |
lung | 100% | 1691.19 | 578 / 578 | 100% | 14.28 | 1155 / 1155 |
stomach | 100% | 1116.07 | 359 / 359 | 100% | 13.60 | 286 / 286 |
prostate | 100% | 1428.16 | 245 / 245 | 100% | 10.97 | 500 / 502 |
ovary | 100% | 1533.88 | 180 / 180 | 100% | 11.95 | 428 / 430 |
brain | 100% | 1711.57 | 2633 / 2642 | 100% | 10.03 | 704 / 705 |
bladder | 100% | 1767.81 | 21 / 21 | 99% | 13.35 | 501 / 504 |
uterus | 100% | 1660.58 | 170 / 170 | 99% | 14.22 | 456 / 459 |
pancreas | 100% | 1011.53 | 328 / 328 | 99% | 9.28 | 176 / 178 |
thymus | 100% | 1431.87 | 652 / 653 | 99% | 10.31 | 597 / 605 |
skin | 100% | 2357.27 | 1809 / 1809 | 97% | 13.01 | 457 / 472 |
kidney | 100% | 1185.21 | 89 / 89 | 95% | 8.84 | 857 / 901 |
liver | 100% | 1283.81 | 226 / 226 | 95% | 6.90 | 385 / 406 |
adrenal gland | 100% | 1321.03 | 258 / 258 | 89% | 7.07 | 204 / 230 |
adipose | 100% | 1857.60 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 19.05 | 29 / 29 |
muscle | 100% | 1568.45 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1568.53 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 15.48 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.22 | 1 / 1 |
blood vessel | 100% | 1548.42 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 96% | 871.11 | 825 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 89% | 7.59 | 71 / 80 |
peripheral blood | 64% | 1097.97 | 593 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006999 | Biological process | nuclear pore organization |
GO_0051028 | Biological process | mRNA transport |
GO_0051315 | Biological process | attachment of mitotic spindle microtubules to kinetochore |
GO_0051301 | Biological process | cell division |
GO_0031669 | Biological process | cellular response to nutrient levels |
GO_0050830 | Biological process | defense response to Gram-positive bacterium |
GO_0034198 | Biological process | cellular response to amino acid starvation |
GO_0006913 | Biological process | nucleocytoplasmic transport |
GO_0015031 | Biological process | protein transport |
GO_1904263 | Biological process | positive regulation of TORC1 signaling |
GO_0007080 | Biological process | mitotic metaphase chromosome alignment |
GO_1904262 | Biological process | negative regulation of TORC1 signaling |
GO_0031503 | Biological process | protein-containing complex localization |
GO_0005643 | Cellular component | nuclear pore |
GO_0000776 | Cellular component | kinetochore |
GO_0061700 | Cellular component | GATOR2 complex |
GO_0035859 | Cellular component | Seh1-associated complex |
GO_0005635 | Cellular component | nuclear envelope |
GO_0005829 | Cellular component | cytosol |
GO_0031080 | Cellular component | nuclear pore outer ring |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0005198 | Molecular function | structural molecule activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SEH1L |
Protein name | Nucleoporin SEH1 (GATOR2 complex protein SEH1) (Nup107-160 subcomplex subunit SEH1) (SEC13-like protein) SEH1 like nucleoporin |
Synonyms | SEC13L SEH1 |
Description | FUNCTION: Component of the Nup107-160 subcomplex of the nuclear pore complex (NPC). The Nup107-160 subcomplex is required for the assembly of a functional NPC . The Nup107-160 subcomplex is also required for normal kinetochore microtubule attachment, mitotic progression and chromosome segregation. This subunit plays a role in recruitment of the Nup107-160 subcomplex to the kinetochore . .; FUNCTION: As a component of the GATOR2 complex, functions as an activator of the amino acid-sensing branch of the mTORC1 signaling pathway . The GATOR2 complex indirectly activates mTORC1 through the inhibition of the GATOR1 subcomplex . GATOR2 probably acts as an E3 ubiquitin-protein ligase toward GATOR1 . In the presence of abundant amino acids, the GATOR2 complex mediates ubiquitination of the NPRL2 core component of the GATOR1 complex, leading to GATOR1 inactivation . In the absence of amino acids, GATOR2 is inhibited, activating the GATOR1 complex . Within the GATOR2 complex, SEC13 and SEH1L are required to stabilize the complex . . |
Accessions | K7EPZ5 ENST00000399892.7 [Q96EE3-1] ENST00000587761.1 ENST00000589446.5 Q96EE3 ENST00000585730.5 K7ELV2 ENST00000262124.15 [Q96EE3-2] ENST00000592170.5 K7ENI5 K7EP88 |